Complete financial analysis of Refined Metals Corp. (RMC.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Refined Metals Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Khaitan Chemicals and Fertilizers Limited (KHAICHEM.BO) Income Statement Analysis – Financial Results
- Ginkgo Bioworks Holdings, Inc. (DNA) Income Statement Analysis – Financial Results
- Aspinwall and Company Limited (ASPINWALL.NS) Income Statement Analysis – Financial Results
- CGS International Inc. (5310.TWO) Income Statement Analysis – Financial Results
- Westone Information Industry Inc. (002268.SZ) Income Statement Analysis – Financial Results
Refined Metals Corp. (RMC.CN)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://refinedmetalscorp.com
About Refined Metals Corp.
Refined Metals Corp., an exploration stage company, engages in the acquisition, exploration, and development of mineral properties. The company was formerly known as Chemesis International Inc. and changed its name to Refined Metals Corp. in November 2022. The company is headquartered in Vancouver, Canada.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 29.32K | 27.84K | 14.09M | 9.31M | 12.92K | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 22.75K | 31.12K | 8.44M | 7.22M | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 6.57K | -3.29K | 5.65M | 2.09M | 12.92K | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 22.41% | -11.80% | 40.09% | 22.41% | 100.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 120.12K | 10.31M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 597.54K | 1.57M | 6.14M | 16.29M | 11.92M | 1.67M | 546.92K | 0.00 |
| Selling & Marketing | 213.00K | 0.00 | 4.78M | 1.79M | 4.23M | 239.30K | 0.00 | 0.00 |
| SG&A | 859.04K | 1.57M | 10.92M | 18.08M | 16.15M | 1.91M | 546.92K | 0.00 |
| Other Expenses | 0.00 | 0.00 | -422.55K | 306.96K | 983.25K | 5.14K | -206.53K | 0.00 |
| Operating Expenses | 859.04K | 1.57M | 10.96M | 22.01M | 27.44M | 1.91M | 546.92K | 0.00 |
| Cost & Expenses | 859.04K | 1.59M | 10.99M | 30.45M | 34.67M | 1.91M | 546.92K | 0.00 |
| Interest Income | 8.50K | 13.17K | 89.21K | 1.27M | 64.98K | 12.92K | 0.00 | 0.00 |
| Interest Expense | 8.50K | 13.17K | 55.75K | 1.58M | 357.12K | 12.92K | 0.00 | 0.00 |
| Depreciation & Amortization | 859.04K | 46.58K | 46.58K | 4.42M | 983.25K | 32.35K | -1.52K | 0.00 |
| EBITDA | -859.04K | -1.52M | -11.25M | -11.63M | -23.64M | -1.92M | -548.43K | 0.00 |
| EBITDA Ratio | 0.00% | -5,192.05% | -40,421.63% | -82.54% | -253.84% | -14,842.23% | 0.00% | 0.00% |
| Operating Income | -859.04K | -1.52M | -9.21M | -13.78M | -25.02M | -1.90M | -546.92K | 0.00 |
| Operating Income Ratio | 0.00% | -5,192.05% | -33,093.89% | -97.76% | -268.71% | -14,691.76% | 0.00% | 0.00% |
| Total Other Income/Expenses | -46.68K | 1.27M | -673.26K | -21.12M | -12.93M | 32.35K | -205.01K | 0.00 |
| Income Before Tax | -905.72K | -252.04K | -12.06M | -38.67M | -37.95M | -1.88M | -751.92K | 0.00 |
| Income Before Tax Ratio | 0.00% | -859.60% | -43,327.90% | -274.41% | -407.57% | -14,541.29% | 0.00% | 0.00% |
| Income Tax Expense | -46.68K | 7.95M | -76.97K | -56.03K | 133.00K | -51.78K | 0.00 | 0.00 |
| Net Income | -905.72K | -8.24M | -18.24M | -36.99M | -37.45M | -1.88M | -751.92K | 0.00 |
| Net Income Ratio | 0.00% | -28,099.43% | -65,519.36% | -262.46% | -402.16% | -14,541.29% | 0.00% | 0.00% |
| EPS | -0.05 | -0.53 | -1.72 | -7.79 | -19.68 | -2.94 | -19.69 | 0.00 |
| EPS Diluted | -0.05 | -0.53 | -1.72 | -7.79 | -19.68 | -2.94 | -19.69 | 0.00 |
| Weighted Avg Shares Out | 19.11M | 15.60M | 10.60M | 4.75M | 1.90M | 638.64K | 38.19K | 846.43K |
| Weighted Avg Shares Out (Dil) | 19.11M | 15.60M | 10.60M | 4.75M | 1.90M | 638.64K | 38.19K | 846.43K |
Source: https://incomestatements.info
Category: Stock Reports